Skip to main content
  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

AACR logo

  • Register
  • Log in
  • My Cart
Advertisement

Main menu

  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

  • AACR Publications
    • Blood Cancer Discovery
    • Cancer Discovery
    • Cancer Epidemiology, Biomarkers & Prevention
    • Cancer Immunology Research
    • Cancer Prevention Research
    • Cancer Research
    • Clinical Cancer Research
    • Molecular Cancer Research
    • Molecular Cancer Therapeutics

User menu

  • Register
  • Log in
  • My Cart

Search

  • Advanced search
Clinical Cancer Research
Clinical Cancer Research
  • Home
  • About
    • The Journal
    • AACR Journals
    • Subscriptions
    • Permissions and Reprints
    • Reviewing
    • CME
  • Articles
    • OnlineFirst
    • Current Issue
    • Past Issues
    • CCR Focus Archive
    • Meeting Abstracts
    • Collections
      • COVID-19 & Cancer Resource Center
      • Breast Cancer
      • Clinical Trials
      • Immunotherapy: Facts and Hopes
      • Editors' Picks
      • "Best of" Collection
  • For Authors
    • Information for Authors
    • Author Services
    • Best of: Author Profiles
    • Submit
  • Alerts
    • Table of Contents
    • Editors' Picks
    • OnlineFirst
    • Citation
    • Author/Keyword
    • RSS Feeds
    • My Alert Summary & Preferences
  • News
    • Cancer Discovery News
  • COVID-19
  • Webinars
  • Search More

    Advanced Search

Human Cancer Biology

Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma

Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju, Yoshihiro Yoshitake, Yutaka Motomura, Yoshiaki Ikuta, Daiki Fukuma, Kazunori Yokomine, Michiko Harao, Toru Beppu, Masanori Matsui, Toshihiko Torigoe, Noriyuki Sato, Hideo Baba and Yasuharu Nishimura
Hiroyuki Komori
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tetsuya Nakatsura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Satoru Senju
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshihiro Yoshitake
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yutaka Motomura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yoshiaki Ikuta
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Daiki Fukuma
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Kazunori Yokomine
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Michiko Harao
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toru Beppu
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Masanori Matsui
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toshihiko Torigoe
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Noriyuki Sato
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Hideo Baba
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Yasuharu Nishimura
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1158/1078-0432.CCR-05-2267 Published May 2006
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Online Impact

Statistics from Altmetric.com

ARTICLE USAGE

ARTICLE USAGE: May 2006 to January 2021

AbstractFull-text HTMLPDF
Total235153993407

Cited By

Article Information

Volume 12, Issue 9, pp. 2689-2697

DOI 
https://doi.org/10.1158/1078-0432.CCR-05-2267
PubMed 
16675560

Published By 
American Association for Cancer Research
Print ISSN 
1078-0432
Online ISSN 
1557-3265
History 
  • Accepted March 2, 2006
  • Received October 20, 2005
  • Revision received February 28, 2006
  • Published first May 4, 2006.

Copyright & Usage 
American Association for Cancer Research

Author Information

  1. Hiroyuki Komori1,2,
  2. Tetsuya Nakatsura1,
  3. Satoru Senju1,
  4. Yoshihiro Yoshitake1,
  5. Yutaka Motomura1,2,
  6. Yoshiaki Ikuta1,2,
  7. Daiki Fukuma1,
  8. Kazunori Yokomine1,
  9. Michiko Harao1,2,
  10. Toru Beppu2,
  11. Masanori Matsui3,
  12. Toshihiko Torigoe4,
  13. Noriyuki Sato4,
  14. Hideo Baba2 and
  15. Yasuharu Nishimura1
  1. Authors' Affiliations: Departments of 1Immunogenetics and 2Gastroenterological Surgery, Graduate School of Medical Sciences, Kumamoto University; 3Department of Microbiology, Saitama Medical School, Saitama; and 4Department of Pathology, Sapporo Medical University School of Medicine, Sapporo, Japan
  1. Requests for reprints:
    Yasuharu Nishimura, Department of Immunogenetics, Graduate School of Medical Sciences, Kumamoto University, Honjo 1-1-1, Kumamoto 860-8556, Japan. Phone: 81-96-373-5310, Fax: 81-96-373-5314; E-mail: mxnishim{at}gpo.kumamoto-u.ac.jp.
View Full Text
PreviousNext
Back to top
Clinical Cancer Research: 12 (9)
May 2006
Volume 12, Issue 9
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover

Sign up for alerts

View this article with LENS

Open full page PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for sharing this Clinical Cancer Research article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma
(Your Name) has forwarded a page to you from Clinical Cancer Research
(Your Name) thought you would be interested in this article in Clinical Cancer Research.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma
Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju, Yoshihiro Yoshitake, Yutaka Motomura, Yoshiaki Ikuta, Daiki Fukuma, Kazunori Yokomine, Michiko Harao, Toru Beppu, Masanori Matsui, Toshihiko Torigoe, Noriyuki Sato, Hideo Baba and Yasuharu Nishimura
Clin Cancer Res May 1 2006 (12) (9) 2689-2697; DOI: 10.1158/1078-0432.CCR-05-2267

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Identification of HLA-A2- or HLA-A24-Restricted CTL Epitopes Possibly Useful for Glypican-3-Specific Immunotherapy of Hepatocellular Carcinoma
Hiroyuki Komori, Tetsuya Nakatsura, Satoru Senju, Yoshihiro Yoshitake, Yutaka Motomura, Yoshiaki Ikuta, Daiki Fukuma, Kazunori Yokomine, Michiko Harao, Toru Beppu, Masanori Matsui, Toshihiko Torigoe, Noriyuki Sato, Hideo Baba and Yasuharu Nishimura
Clin Cancer Res May 1 2006 (12) (9) 2689-2697; DOI: 10.1158/1078-0432.CCR-05-2267
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
    • Abstract
    • Materials and Methods
    • Results
    • Discussion
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
Advertisement

Related Articles

Cited By...

More in this TOC Section

  • MET in Papillary RCC
  • Identification of T-cell Antigens by Minigene Screening
  • Sirt7 Promotes Colorectal Cancer Tumorigenesis
Show more Human Cancer Biology
  • Home
  • Alerts
  • Feedback
  • Privacy Policy
Facebook  Twitter  LinkedIn  YouTube  RSS

Articles

  • Online First
  • Current Issue
  • Past Issues
  • CCR Focus Archive
  • Meeting Abstracts

Info for

  • Authors
  • Subscribers
  • Advertisers
  • Librarians

About Clinical Cancer Research

  • About the Journal
  • Editorial Board
  • Permissions
  • Submit a Manuscript
AACR logo

Copyright © 2021 by the American Association for Cancer Research.

Clinical Cancer Research
eISSN: 1557-3265
ISSN: 1078-0432

Advertisement